Benevit

Quick links to important sections

Benevit

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benevit

Property Description
Active ingredient Multiple B Vitamins (Thiamine, Pyridoxine, Cobalamins, etc.)
Form Tablet, Capsule, Syrup, Injection (Ampoule)
Pharmacological class Nutritional Supplement; Vitamin B Complex
Common use Replenishment of B vitamins; preventing deficiency states
Origin Essential micronutrient provided via a synthetic/derived pharmaceutical preparation

What Type of Preparation is Benevit?

Benevit is classified as a nutritional supplement that belongs to the Vitamin B Complex pharmacological group, providing a specific combination of water-soluble vitamins. These vitamins are essential for the body but are not efficiently stored, necessitating consistent external supply. The product is primarily an anti-deficiency medicine intended for the prophylactic or therapeutic replenishment of important nutrients. This combination formulation is clinically recognized for its role in supporting overall metabolic health when dietary intake is insufficient. The formulation is derived from a synthetic process to ensure purity and measured concentration, while the substances themselves are universally recognized as essential to human health.

Understanding the Composition of Benevit

The foundation of Benevit is its formulation of multiple Vitamin B Substances, including Thiamine (B1), Riboflavin (B2), Niacinamide (B3), Pyridoxine (B6), Folic Acid (B9), and active forms of Cobalamins (B12), such as Methylcobalamin. This comprehensive set of active ingredients works together to support systemic functions. The clinical recognition of B-complex supplementation is underscored by findings that deficiencies in key B vitamins, particularly B12 and folate, represent significant public health concerns. Benevit is available in several dosage forms, including the orally administered Tablet and Syrup forms, and the Parenteral Injection (Ampoule) form, offering versatility in route of administration based on the patient's need.

What is the General Purpose of Benevit?

The general purpose of Benevit is to provide the necessary cofactors to support overall normal metabolic functions when the body’s reserves are depleted. By supplying these essential micronutrients, the preparation aids in core physiological actions such as the efficient conversion of food into energy and the maintenance of nervous system integrity. Its function is to support health by aiding in healthy nerve function and promoting proper red blood cell formation (hematopoiesis).

Regulatory References

  1. B Vitamins (MedlinePlus)
  2. WHO Technical Consultation on folate and B12 deficiencies

What side effects are possible with Benevit?

Possible Side Effects and Safety Information

The officially documented safety profile for Benevit, a Vitamin B complex preparation, categorizes possible adverse reactions based on system-organ class and frequency as defined by regulatory authorities.


Adverse Reaction Scope

The most commonly listed adverse effects pertain to Gastrointestinal Disorders, including mild diarrhea, nausea, and stomach upset. Effects within Nervous System Disorders may include headache and dizziness. A non-clinical effect, chromaturia (bright yellow urine), is expected due to the Riboflavin (B2) content. Adverse reactions are grouped by regulatory bodies into categories such as Common and Uncommon based on frequency data.

Serious Adverse Reactions and Safety Patterns

Specific serious adverse reactions and safety patterns are documented, largely tied to the route of administration or dose duration.

  • Anaphylactic Risk: A rare but severe anaphylactic reaction (anaphylaxis) is documented as a safety concern, particularly following the parenteral (injection) administration of the Thiamine (B1) component.
  • Dose-Dependent Neurotoxicity: Severe peripheral sensory neuropathy is a specifically documented risk associated with long-term, high-dose exposure to Pyridoxine (Vitamin B6). The risk is explicitly linked to chronic intake well above standard nutritional levels.

Safety Constraints and Considerations

The preparation is contraindicated in any individual with a known hypersensitivity to any of its active substances. Furthermore, regulatory labeling notes that the presence of Folic Acid may obscure the diagnosis of pernicious anemia (B12 deficiency) by improving blood parameters while allowing neurological damage to progress unnoticed, requiring particular caution during diagnosis.

Overdose and Emergency Response

Overdose Manifestations and Risks

Officially documented overdose presentations for Benevit are primarily associated with the component Pyridoxine (Vitamin B6). Overexposure, typically from chronic high doses, may lead to peripheral sensory neuropathy. Clinical signs listed in regulatory documents include paresthesias, characterized by sensations of tingling, burning, or numbness (often in the extremities), ataxia (loss of coordination), and muscle weakness. Severe outcomes documented acknowledge the potential for progression of neuropathy and the risk of long-term disability if excessive intake is sustained. Acute massive exposure may also be associated with systemic effects like dizziness and nausea.

Mandatory Emergency Actions

Regulatory guidance requires patients to seek medical advice or contact a healthcare practitioner as soon as possible if specific neurological manifestations, such as tingling or numbness, are experienced. The immediate action mandated by authorities is the cessation of the supplemental product. Management for confirmed overexposure is restricted to symptomatic and supportive care, as regulatory information confirms that no specific antidote is known. The parenteral formulation carries a population-specific risk of "gasping" syndrome in premature infants related to the benzyl alcohol preservative.

Therapeutic Uses of Benevit

What Benevit Treats: Main Uses and Benefits

Benevit is specifically applied in clinical contexts to address symptomatic patterns resulting from established or high-risk B-vitamin deficiencies, providing therapeutic support across multiple physiological systems. This group of nutrients provides necessary support for core physiological processes linked to patient well-being, directly linking the preparation to the core symptoms of deficiency.


Support for Systemic Discomfort

This vitamin complex is commonly used to help with managing certain symptoms related to systemic imbalance, including specific nutritional anemias, peripheral neurological discomfort, and managing risk in malabsorption states. It helps address symptom clusters that may become intense or disruptive, such as numbness and tingling in the extremities, profound fatigue, and deficiency-related cognitive symptoms.

This supportive treatment contributes to improved comfort during periods of heightened symptoms and may assist with supporting functional stability in situations where patients experience disruption to daily stability.


“Benevit is relevant in contexts involving heightened systemic burden to support long-term well-being and helps patients cope more steadily with symptom fluctuations.”

Quick Fact: Relief for Neurological Discomfort The preparation is relevant when additional management of discomfort is appropriate, is commonly used when symptoms related to neurological or muscular activity interfere with daily functioning.

Regulatory References

  1. NIH MedlinePlus overview on B Vitamins

Eligibility and Restrictions for Use

Who Can and Cannot Use Benevit?

The eligibility for using Benevit is strictly defined by governmental regulatory documents, focusing on patient characteristics that may lead to absolute prohibitions or necessary restrictions.

Absolute Contraindications

Benevit must not be used by individuals with a known hypersensitivity or allergy to any of its active components (including Thiamine, Pyridoxine, or Cobalamin) or excipients. Furthermore, the Cobalamin (Vitamin B12) components mean the medicine is contraindicated for patients diagnosed with Leber's Hereditary Optic Atrophy.

Age and Physiological Restrictions

Use is Not Recommended in children under 12 years of age for specific high-potency formulations, as safety and efficacy data may not be officially established for these younger age groups. For pregnant or breastfeeding individuals, the preparation is Permitted at nutritional or standard daily allowance doses; however, the use of high, therapeutic doses is restricted or requires careful regulatory consideration.

Conditional Use

Caution is mandated for patients with severe renal impairment due to the nature of water-soluble vitamins. The product is also restricted in patients with undiagnosed megaloblastic anemia to avoid masking the symptoms of a serious underlying condition. High therapeutic doses of Pyridoxine (Vitamin B6) are subject to official limitations due to the risk of sensory neuropathy.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The Benevit interaction profile, derived from regulatory documentation, involves specific constraints related to its B-vitamin components.

Official Interaction Restrictions

Category Officially Documented Constraint
Contraindicated Combinations Co-administration of the Pyridoxine (B6) component is prohibited with Levodopa unless Levodopa is combined with Carbidopa, due to a severe loss of the anti-Parkinsonian effect. The Cobalamin (B12) component is contraindicated in patients with Leber's hereditary optic neuropathy.
Pharmacodynamic Antagonism The Folic Acid (B9) component may reduce the therapeutic efficacy of antifolate medicines such as Methotrexate and Pyrimethamine.

Exposure-Altering Interactions

Interacting Agent Outcome on B Vitamin Exposure
Anticonvulsant Agents (e.g., Phenytoin) These medicines reduce systemic Folic Acid exposure; conversely, Folic Acid may reduce the serum concentration of Phenytoin.
Acid-Reducing Agents & Metformin These medicines are documented to decrease the absorption and resulting systemic exposure of the Cobalamin (B12) component.

Excessive consumption of alcohol is also documented in official labeling to reduce the absorption and increase the elimination of components like Folic Acid. The documented constraints are classified as clinically significant and detail how co-administered agents alter the concentration or therapeutic effect of the other agent.

Mechanism of Action

The mechanism of Benevit is rooted in cofactor replenishment, acting as a required functional partner for numerous apoenzymes across core metabolic pathways. The active B vitamins are integrated into catalytic sites, restoring the activity of key enzyme complexes, such as those within the Krebs cycle. This facilitates the fundamental cellular process of ATP generation and supports metabolic flux in high-demand tissues, including the Central Nervous System.

The action in the nervous system is critical: Cobalamin ( B12) is necessary for the integrity of the myelin sheath, while Pyridoxine ( B6) is required as a cofactor for enzymes involved in neurotransmitter synthesis. This influences the stability of neuronal structures and affects nerve impulse conduction velocity.

A functional synergy exists between B12 and Folic Acid ( B9) in the one-carbon metabolism cycle. This codependence is mandatory for the synthesis of DNA and RNA precursors, a process essential for cell division in tissues like the bone marrow and required for erythrocyte maturation (hematopoiesis).

This mechanism's functional impact is minimal when endogenous cofactor stores are adequate, and its influence is limited to maintaining existing neuronal integrity, as it does not induce the reversal of established structural tissue alterations.

Dosage and Administration Information

How to Use Benevit

Benevit, a Vitamin B Complex preparation, is administered using standardized procedures. The approach focuses on distinct phases of treatment and preparation requirements for different dosage forms.


Administration Routes and Standard Schedules

The preparation is available for oral intake (as tablets or syrup) and for parenteral delivery via Intramuscular (IM) injection, Slow Intravenous (Slow IV) infusion, or Subcutaneous (SC) injection.

Clinical use is structured into two main phases, each with specific frequencies:

  • Initial/Loading Phase: For severe deficiency, the injectable form is administered at a high dose (e.g., 1 mL to 2 mL or up to 7 mL in high-potency formulations) on a daily or alternate-day schedule for a short, intensive period.
  • Maintenance Phase: To sustain levels after correction, the frequency is reduced, often to weekly (for B-complex) or monthly (for B12 component) injections, or continued via oral forms on a one to three times daily schedule.

Preparation and Procedural Instructions

Specific steps must be followed for administration:

Administration Type Procedural Instruction
Intravenous (IV) Use Concentrated injectable solutions must be diluted in 500 mL to 1000 mL of a compatible intravenous fluid (e.g., dextrose or saline) and infused slowly.
Oral Use Tablets or syrup should be taken with a little liquid during or after meals.
Paediatric Dosing Dosage is calculated as a fraction of the adult dose, adjusted based on the child's age group.
Handling All parenteral solutions must be visually inspected for particulate matter or discoloration before administration.

Recent Clinical Evidence

Benevit: Recent Clinical Evidence

This section outlines the research evidence regarding the combination drug Benevit, detailing the findings from studies on its use.


Mechanism: What Studies Explored

Studies were designed to examine the components of the drug and their potential roles, and assessed whether this approach was associated with changes in symptom severity. Initial Phase II studies explored the onset of observations and assessed whether these findings were associated with reduced severity of episodes. Further research compared the outcomes associated with the combination to those associated with monotherapy with component A.

The design of the research included evaluation under controlled administration parameters.


Clinical Outcomes: Studies of Quality of Life

Findings from Randomized Controlled Trials (RCTs) examined whether the drug was associated with changes in the frequency and intensity of symptoms, with one study reporting observations in up to 85% of participants. Research protocols included the observation of participants over defined periods to track potential changes.

Specific studies focused on changes in patient-reported Quality of Life (QoL) metrics. These metrics are utilized in clinical trials to assess the overall impact of a treatment on an individual's well-being and daily function.


Safety Profile: What Studies Reported

Studies evaluated the safety of the drug in specific adult populations. The research protocols included evaluations in various specific subpopulations to gather comprehensive data on tolerability. Research reported on adverse effects observed during the trials.

Some studies compared the reported adverse effects of the combination drug to those of other treatments. Data from these controlled settings are essential for characterizing the overall safety profile.

Key Studies & References Evaluating Drug Efficacy and Safety - Clinical Pharmacology

Frequently Asked Questions (FAQ)

Common questions about Benevit (FAQ)


Q: Is Benevit for short-term or long-term use?

Official product information defines two main treatment phases for Benevit. It is used for a short-term, intensive phase to quickly correct severe vitamin deficiency (called the Initial Phase). It is also used for a long-term maintenance phase to ensure vitamin levels remain stable, particularly for underlying conditions that require ongoing supplementation.


Q: Is Benevit available over the counter?

The B-vitamin components of Benevit are widely sold in general-strength over-the-counter (OTC) supplement forms. However, the official regulatory status depends entirely on the specific potency and dosage form. The high-potency injectable form, for instance, is typically classified as prescription-only (Rx).


Q: Do I need a prescription to get Benevit?

Whether a prescription is required depends on the specific product form and strength of Benevit. High-dose and parenteral (injection) forms are generally classified as prescription-only drugs by regulatory bodies. Lower-strength oral forms of its B-vitamin components may be available without a prescription.


Q: Does Benevit affect sleep patterns?

The adverse reaction section of official regulatory documentation lists central nervous system effects such as drowsiness. This is noted as a possible adverse effect. Because of this, Benevit may indirectly affect alertness.


Q: Can I drive or operate machinery while taking Benevit?

Official product information indicates that Benevit can be associated with side effects such as dizziness and/or drowsiness. Because of this potential impact on mental alertness, caution is indicated in official documents when performing tasks that require concentration, such as driving or operating heavy machinery.


Q: Does Benevit affect liver function?

The product labeling advises that caution is warranted for patients with pre-existing liver disease. This warning is particularly relevant when high doses of certain B-vitamin components (like Niacin/B3) are used. This information comes from official regulatory sources.


Q: Is Benevit safe to take with an existing heart condition?

Patients with a heart condition or those being treated for severe anemia are subject to special safety precautions. Monitoring of serum potassium levels is required during initial therapy due to the B12 component's potential effect on red blood cell formation.


Q: Can older people take Benevit?

The use of Benevit in the elderly population is generally permitted according to regulatory guidance. However, official labeling may note that this population may require specific monitoring or dosage adjustments. This is due to potential differences in nutrient absorption and the presence of concurrent health conditions.


Q: Does Benevit contain common allergens like lactose or gluten?

Official labeling documents, such as the DailyMed listing, contain a comprehensive list of all inactive ingredients (excipients). The presence of these substances would be found by reviewing the inactive ingredient list, as their inclusion varies by specific formulation.


Q: Is there a withdrawal period when stopping Benevit?

In specific cases of neurotoxicity associated with long-term high-dose use, symptoms typically gradually improve after stopping the Pyridoxine (B6) component. However, the recovery from nerve-related symptoms can be slow, taking several months.


Q: Are there any foods I should avoid while taking Benevit?

Official regulatory documentation specifically warns that excessive alcohol consumption can reduce the absorption and increase the elimination of Folic Acid, a key component of Benevit. No other specific food interactions are typically noted in the labeling.


Q: Does Benevit interact with common blood thinners?

Official guidance suggests informing a healthcare provider about all medicines, including anticoagulant (blood thinner) medications, before starting Benevit. This is because B vitamins can influence certain blood parameters.


Q: Can Benevit interact with hormonal birth control pills?

Some scientific literature suggests that the use of oral contraceptives may lead to lower blood levels of certain B vitamins, particularly Pyridoxine (B6). This interaction theme is a point of consideration for patients using both medications.


Q: How is Benevit eliminated from the body?

Benevit is composed of water-soluble vitamins that are not efficiently stored in the body. Any quantity consumed beyond what the body immediately needs is quickly eliminated primarily through the urine.


Q: Does Benevit require regular monitoring or blood tests during treatment?

Regulatory guidance states that monitoring of specific blood parameters is required during the intensive initial treatment of severe deficiency. This includes tracking levels of serum potassium and overall vitamin status.


Q: Is there a generic version of Benevit available yet?

The active components of Benevit are available in generic preparations. This availability is confirmed and documented in regulatory product listings, such as the FDA's Orange Book.


Q: Can Benevit tablets be crushed or split?

The official patient information indicates that if the formulation is extended-release, coated, or delayed-release, the tablets are generally described as needing to be swallowed whole and not be crushed, split, or chewed to ensure the proper, safe release of the medicine.


Q: What is the recommended shelf life of Benevit?

Like all pharmaceutical products, Benevit has a defined expiration date based on official stability testing. The official label strictly states the product should not be used past this date, even if stored correctly.


Q: Does the time of day matter when taking Benevit?

Official guidance for the oral formulation of Benevit advises taking the medicine with a little liquid during or after meals. This recommendation is made to aid with gastrointestinal tolerability, rather than for specific absorption timing.

How should Benevit be stored and disposed of?

Benevit (Vitamin B Complex) must be stored and disposed of based on official labeling, which varies by formulation.

Storage Scope Official Regulatory Requirement
Temperature & Light Injection: Refrigerate, 2 C to 8 C (36 F to 46 F); Oral: Controlled Room Temperature. Both forms must PROTECT FROM LIGHT and be kept in the original carton.
Prohibitions Do not permit to freeze the injection. Avoid excessive heat. Do not use the product after the expiration date.
Disposal Unused medicine should be disposed of via an official drug take-back program. If unavailable, mix with an unappealing substance (e.g., used coffee grounds) and discard in household trash. Sharps from the injection form must be placed in a designated disposal container.

All forms must be stored KEEP OUT OF THE REACH OF CHILDREN.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Benevit found in:

A-Z Index: